Studies on the synthesis of extremely potent antitumor hybride steroidal dimer

极强抗肿瘤杂合甾体二聚体的合成研究

基本信息

  • 批准号:
    16590018
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2006
  • 项目状态:
    已结题

项目摘要

Wittig rearrangement has been established as one of the most useful synthetic tools in organic synthesis. Considerable variation in Wittig rearrangement has been explored and widely applied to natural product synthesis. In a continuation of these efforts, we were interested in the development of Wittig rearrangement under neutral condition. We considered the possibility that a-allyloxymalonates undergo [2,3]-sigmatropic rearrangement under the Krapcho reaction condition. Treatment of dimethyl a-allyloxymalonates with lithium chloride in HMPA at 130-140℃ for 5-30 min resulted in sequential Wittig rearrangement and demethoxycarbonylation. This afforded methyl 2-hydroxy-4-pentenoate derivatives in 55-96% yields with high E selectivity. Its application to steroidal side chain synthesis was also carried out. Sequential Wittig rearrangement and demethoxycarbonylation of (E)-17(20)-pregnen-16a-yloxymalonate furnished (20S,22S)-and (20S,20R)-22-hydroxy steroids in a ratio of 76:24, respectively. Major isomer, (20S,22S)-steroid, could be a key intermediate for the synthesis of biologically active ecdysteroid, withanolide, OSW-1, and cephalostatin.We have accomplished the synthesis of an extremely potent antitumor saponin OSW-1 and its analogues by means of the Wittig rearrangement of allylic thiophenemethyl ether for the construction of (20S)-22-hydroxy steroidal side chain. Thus, Wittig rearrangement of 17E(20)-ethylidene-16α-thiophenemethyloxy steroid, prepared from commercially available epoxy ketone, afforded (20S)-22-hydroxy steroid in 59% yield. Introduction of trans diol functionality at the C(16) and C(17) positions was carried out by usual methods to give 16β,17α-diol. Glycosylation of the accepter with disaccharide imidate, synthesized by the known protocol, proceeded smoothly under the promotion of TMSOTf to give the desired β-glycoside. Removal of all protecting groups followed by desulphurization furnished OSW-1.
维蒂格重排已成为有机合成中最有用的合成工具之一。Wittig重排的大量变异已被探索并广泛应用于天然产物的合成。在这些努力的延续中,我们对中性条件下Wittig重排的发展感兴趣。我们考虑了a-烯丙基丙二酸盐在Krapcho反应条件下发生[2,3]-异位重排的可能性。二甲基a-烯丙氧基丙二酸酯在130 ~ 140℃下用氯化锂处理5 ~ 30 min,得到了连续的Wittig重排和去甲氧基羰基化反应。这提供了2-羟基-4-戊酸甲酯衍生物,收率为55-96%,具有高E选择性。并将其应用于甾体侧链的合成。(E)-17(20)-孕酮-16a-羟丙二酸酯的顺序Wittig重排和去甲氧基羰基化分别以76:24的比例提供(20S,22S)和(20S,20R)-22羟基类固醇。主要同分异构体(20S,22S)-甾体可能是合成具有生物活性的表皮甾体、威纳醇内酯、OSW-1和头孢司他汀的关键中间体。本文通过烯丙基噻吩甲醚的Wittig重排,构建了(20S)-22羟基甾体侧链,合成了极有效的抗肿瘤皂苷OSW-1及其类似物。由此,以市售环氧酮为原料制备的17E(20)-乙基-16α-噻吩甲氧基甾体,通过Wittig重排得到(20S)-22-羟基甾体,收率为59%。采用常规方法在C(16)和C(17)位置引入反式二醇官能团,得到16β,17α-二醇。在TMSOTf的促进下,根据已知方案合成的受体与酰二糖的糖基化过程顺利进行,得到所需的β-糖苷。去除所有保护基团,然后脱硫提供OSW-1。

项目成果

期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Analysis of antitumor activc OSW-1 and its analogues by liquid chromatography coupled with electrospray-
液相色谱-电喷雾联用分析抗肿瘤活性 OSW-1 及其类似物
Wittig rearrangement of allyl 2-thiophenemethyl ethers : Facile synthesis of thiophenemethanol and -ethanol derivatives
  • DOI:
    10.3987/com-05-s(k)5
  • 发表时间:
    2005-12
  • 期刊:
  • 影响因子:
    0.6
  • 作者:
    M. Tsubuki;Sohichiro Matsuo;T. Honda
  • 通讯作者:
    M. Tsubuki;Sohichiro Matsuo;T. Honda
Analysis of antitumor active OSW-1 and its analogues by liquid chromatography coupled with electrospray and atmospheric pressure chemical ionization quadrupole mass spectrometry
液相色谱-电喷雾-大气压化学电离四极杆质谱分析抗肿瘤活性OSW-1及其类似物
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    H.F.Kasai;M.Tsubuki;S.Matsuo;Toshio Honda
  • 通讯作者:
    Toshio Honda
Studies on Wittig rearrangement of furfuryl ethers in steroidal side chain synthesis
甾体侧链合成中糠醚Wittig重排的研究
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Takanami;T.;Hayashi;M.;Chijimatsu;H.;Inoue;W.;Suda;K.;M.Tsubuki et al.
  • 通讯作者:
    M.Tsubuki et al.
Studies on the construction of abutasterone-type and 24-epi-abutasterone-type side chains employing asymmetric dihydroxylation of (E)-20(22),24-cholestadiene
利用(E)-20(22),24-胆甾二烯不对称二羟基化构建阿布甾酮型和24-表阿布甾酮型侧链的研究
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Y.M.A.Yamada;H.Tabata;M.Ichinohe;H.Takahashi;S.Ikegami^*;M.Tsubuki et al.
  • 通讯作者:
    M.Tsubuki et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUBUKI Masayoshi其他文献

TSUBUKI Masayoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUBUKI Masayoshi', 18)}}的其他基金

Rational Development of Novel Hemagglutinin-based Influenza Virus Inhibitors
新型血凝素流感病毒抑制剂的合理开发
  • 批准号:
    26460158
  • 财政年份:
    2014
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on the synthesis of potent antitumor hybrids of the spliceosome inhibitors FR901464 and pladienolide
剪接体抑制剂 FR901464 和 pladienolide 的有效抗肿瘤杂合体的合成研究
  • 批准号:
    22590022
  • 财政年份:
    2010
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on the synthesis of physiologically active furanocembrane derivatives
生理活性呋喃西松衍生物的合成研究
  • 批准号:
    13672238
  • 财政年份:
    2001
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Wittig rearrangement of furylmethyl ethers and application to natural product synthesis
呋喃甲基醚的Wittig重排及其在天然产物合成中的应用
  • 批准号:
    11672121
  • 财政年份:
    1999
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Synthetic Study Directed toward the Squalene Synthase Inhibitor Zaragozic Acid and Squalestatin
角鲨烯合酶抑制剂萨拉哥酸和角鲨烯他汀的合成研究
  • 批准号:
    06672119
  • 财政年份:
    1994
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

OSW-1诱导结直肠癌坏死性凋亡机制及应用研究
  • 批准号:
    2023JJ40987
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
OSW-1介导miRNA/UCP2诱发肝癌细胞凋亡、自噬机制研究
  • 批准号:
    82160764
  • 批准年份:
    2021
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目
强效抗癌甾体皂苷OSW-1的组合生物合成研究
  • 批准号:
    2020A151501926
  • 批准年份:
    2020
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
OSW-1对肝癌的治疗及影响肿瘤细胞信号传导的机理研究
  • 批准号:
    81160529
  • 批准年份:
    2011
  • 资助金额:
    50.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Antitumor Activity & Mechanism of OSW-1 in Pancreatic Ca
抗肿瘤活性
  • 批准号:
    6882616
  • 财政年份:
    2004
  • 资助金额:
    $ 2.18万
  • 项目类别:
Antitumor Activity & Mechanism of OSW-1 in Pancreatic Ca
抗肿瘤活性
  • 批准号:
    6719360
  • 财政年份:
    2004
  • 资助金额:
    $ 2.18万
  • 项目类别:
Design and Synthesis of New Anticancer Agents Based on OSW-1 Having Potent Antitumor Activity as a Lead Compound
以具有有效抗肿瘤活性的 OSW-1 作为先导化合物的新型抗癌药物的设计与合成
  • 批准号:
    15390004
  • 财政年份:
    2003
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了